Citadel Advisors’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.26M | Buy |
383,058
+71,743
| +23% | +$906K | ﹤0.01% | 4606 |
|
|
2025
Q4 | $5.16M | Sell |
311,315
-197,405
| -39% | -$2.82M | ﹤0.01% | 4241 |
|
|
2025
Q3 | $5.99M | Buy |
+508,720
| New | +$5.25M | ﹤0.01% | 4031 |
|
|
2025
Q2 | – | Sell |
-179,721
| Closed | -$994K | – | 14460 |
|
|
2025
Q1 | $1.13M | Buy |
179,721
+107,714
| +150% | +$654K | ﹤0.01% | 6702 |
|
|
2024
Q4 | $585K | Sell |
72,007
-148,396
| -67% | -$1.84M | ﹤0.01% | 8215 |
|
|
2024
Q3 | $3.98M | Buy |
220,403
+141,587
| +180% | +$1.98M | ﹤0.01% | 4317 |
|
|
2024
Q2 | $812K | Sell |
78,816
-46,829
| -37% | -$482K | ﹤0.01% | 7013 |
|
|
2024
Q1 | $1.33M | Buy |
125,645
+114,112
| +989% | +$969K | ﹤0.01% | 6336 |
|
|
2023
Q4 | $105K | Sell |
11,533
-264,194
| -96% | -$2.28M | ﹤0.01% | 10868 |
|
|
2023
Q3 | $2.86M | Buy |
275,727
+258,812
| +1,530% | +$3.55M | ﹤0.01% | 4562 |
|
|
2023
Q2 | $242K | Sell |
16,915
-171,569
| -91% | -$1.98M | ﹤0.01% | 9476 |
|
|
2023
Q1 | $1.35M | Buy |
188,484
+186,731
| +10,652% | +$1.64M | ﹤0.01% | 6144 |
|
|
2022
Q4 | $19.7K | Buy |
+1,753
| New | +$18.1K | ﹤0.01% | 13156 |
|
|
2022
Q3 | – | Sell |
-25,012
| Closed | -$238K | – | 13349 |
|
|
2022
Q2 | $212K | Buy |
+25,012
| New | +$257K | ﹤0.01% | 10583 |
|
|
2022
Q1 | – | Sell |
-11,466
| Closed | -$185K | – | 14337 |
|
|
2021
Q4 | $226K | Sell |
11,466
-7,944
| -41% | -$187K | ﹤0.01% | 11599 |
|
|
2021
Q3 | $623K | Sell |
19,410
-60,964
| -76% | -$2.03M | ﹤0.01% | 9337 |
|
|
2021
Q2 | $2.72M | Buy |
80,374
+71,833
| +841% | +$2.57M | ﹤0.01% | 5845 |
|
|
2021
Q1 | $321K | Sell |
8,541
-3,535
| -29% | -$148K | ﹤0.01% | 10698 |
|
|
2020
Q4 | $401K | Buy |
12,076
+5,360
| +80% | +$217K | ﹤0.01% | 8565 |
|
|
2020
Q3 | $246K | Buy |
+6,716
| New | +$233K | ﹤0.01% | 8467 |
|
|
2020
Q2 | – | Sell |
-11,948
| Closed | -$308K | – | 10326 |
|
|
2020
Q1 | $308K | Buy |
+11,948
| New | +$399K | ﹤0.01% | 7296 |
|
Other funds holding PHAT
FLSM
MVM
CG
VCM
NMC
6CM
